Speciality: Obstetric Medicine
Description:
Pregnancy can be a challenging time for women with autoimmune diseases, as hormonal and immune system changes may trigger disease flares. Recent advances in longitudinal immune phenotyping offer new hope. By regularly monitoring the immune system throughout pregnancy, doctors can identify early signs of immune imbalance. This allows for timely interventions—such as adjusting medications or lifestyle changes—to prevent disease worsening. Longitudinal immune phenotyping provides a personalized approach, tailored to each woman’s unique immune profile. Ultimately, this proactive monitoring could improve pregnancy outcomes for women with autoimmune conditions, ensuring better health for both mother and baby.
See More Webinars @ Hidoc Webinars
1.
Three out of ten breast cancers detected between screenings, study finds
2.
Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments
3.
Where Did This Very Painful Gluteal Mass Come From?
4.
As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.
5.
Rucaparib Delays Next Lines of Therapy in Ovarian Cancer
1.
Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know
2.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
3.
Unleashing the Oncolytic Arsenal: Talimogene Laherparepvec Monotherapy – A Targeted Cancer Immunotherapy Treatment
4.
Clonal Hematopoiesis Dynamics and Future Hematologic Outcomes
5.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
2.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
3.
Evidence-Based Oncology
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Preventing Immune Effector Cell-Associated Neurotoxicity Through Early Neurovascular Biomarker Surveillance
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation